Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)

September 13, 2024 6:40 AM EDT Send to a Friend
Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating and $75.00 price target on Exact Sciences (NASDAQ: EXAS).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login